MENU
+Compare
OMCL
Stock ticker: NASDAQ
AS OF
Dec 23, 10:32 AM (EDT)
Price
$44.65
Change
-$0.33 (-0.73%)
Capitalization
1.31B

OMCL Omnicell Forecast, Technical & Fundamental Analysis

a provider of automated solutions for hospital medication and supply management

OMCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for OMCL with price predictions
Dec 20, 2024

OMCL's Stochastic Oscillator is staying in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OMCL advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

OMCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on OMCL as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OMCL turned negative on November 14, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

OMCL moved below its 50-day moving average on December 17, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OMCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OMCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.106) is normal, around the industry mean (31.082). P/E Ratio (476.190) is within average values for comparable stocks, (160.694). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.755). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (1.128) is also within normal values, averaging (58.159).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
OMCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OMCL is expected to report earnings to rise 3.96% to 58 cents per share on February 06

Omnicell OMCL Stock Earnings Reports
Q4'24
Est.
$0.58
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.37
Q1'24
Beat
by $0.12
Q4'23
Beat
by $0.18
The last earnings report on October 30 showed earnings per share of 56 cents, beating the estimate of 41 cents. With 2.54K shares outstanding, the current market capitalization sits at 1.31B.
A.I. Advisor
published General Information

General Information

a provider of automated solutions for hospital medication and supply management

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Information Technology Services
Address
4220 North Freeway
Phone
+1 877 415-9990
Employees
3650
Web
https://www.omnicell.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GFVIX15.470.19
+1.24%
Goldman Sachs Focused Value Inv
CDVZX16.200.15
+0.93%
Columbia Large Cap Value Inst
HWSCX54.310.39
+0.72%
Hotchkis & Wiley Small Cap Value C
NTKLX58.250.36
+0.62%
Voya Multi-Manager International Sm Cp A
MGRBX38.320.04
+0.10%
MFS International Growth B

OMCL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OMCL has been loosely correlated with FFIV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OMCL jumps, then FFIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMCL
1D Price
Change %
OMCL100%
+1.33%
FFIV - OMCL
44%
Loosely correlated
+0.73%
RIOT - OMCL
43%
Loosely correlated
+3.22%
CLSK - OMCL
43%
Loosely correlated
+2.11%
COIN - OMCL
40%
Loosely correlated
+1.75%
CWAN - OMCL
38%
Loosely correlated
+2.79%
More